Evidence mapPaperPMID 39015154Full record

ArticleTransplant international : official journal of the European Society for Organ Transplantation2024

Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT.

Maria Simonenko, Dominique Hansen, Josef Niebauer, Maurizio Volterrani, Stamatis Adamopoulos, Cristiano Amarelli, Marco Ambrosetti, Stefan D Anker, Antonio Bayes-Genis, Tuvia Ben Gal and 31 more

Abstract readConsensus Statement
In one paragraph

Article in Transplant international : official journal of the European Society for Organ Transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. The Path Forward: A Review on Enhanced Recovery After Cardiothoracic Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors.

Maria SimonenkoCardiopulmonary Exercise Test Research Department, Heart Transplantation Outpatient Department, V. A. Almazov National Medical Research Centre, St. Petersburg, Russia.
Dominique HansenREVAL and BIOMED Rehabilitation Research Center, Hasselt University, Hasselt, Belgium.
Josef NiebauerUniversity Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University, Salzburg, Austria.
Maurizio VolterraniCardio-Pulmonary Department, IRCCS San Raffaele Roma, Rome, Italy.
Stamatis AdamopoulosHeart Failure and Heart Transplantation Unit, Onassis Cardiac Surgery Center, Athens, Greece.
Cristiano AmarelliDepartment of Cardiac Surgery and Transplants, Monaldi Hospital, Azienda dei Colli, Naples, Italy.
Marco AmbrosettiCardiovascular Rehabilitation Unit, ASST Crema, Santa Marta Hospital, Rivolta D'Adda, Italy.
Stefan D AnkerDepartment of Cardiology (CVK), Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
Antonio Bayes-GenisUniversity Hospital Germans Trias and Pujol de Badalona, Badalona, Spain.
Tuvia Ben GalHeart Failure Unit, Cardiology Department, Rabin Medical Center, Petah Tikva and Sackler, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
T Scott BowenSchool of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.
Francesco CacciatoreDepartment of Translational Medicine, University of Naples "Federico II", Naples, Italy.
Giuseppe CaminitiCardio-Pulmonary Department, IRCCS San Raffaele Roma, Rome, Italy.
Elena CavarrettaDepartment of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy.
Ovidiu ChioncelEmergency Institute for Cardiovascular Diseases "Prof. C. C. Iliescu", Bucharest, Romania.
Andrew J S CoatsHeart Research Institute, Sydney, NSW, Australia.
Alain Cohen-SolalCardiology Department, University of Paris, INSERM UMRS-942, Hopital Lariboisiere, AP-HP, Paris, France.
Flavio D'AscenziDivision of Cardiology, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Carmen de Pablo ZarzosaDepartment of Cardiology, Ramón y Cajal University Hospital, Madrid, Spain.
Andreas B GevaertResearch Group Cardiovascular Diseases, Genetics, Pharmacology and Physiopathology of Heart, Blood Vessels and Skeleton (GENCOR) Department, University of Antwerp, Antwerp, Belgium.
Finn GustafssonDepartment of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Hareld KempsDepartment of Cardiology, Maxima Medical Centre, Eindhoven, Netherlands.
Loreena HillSchool of Nursing and Midwifery, Queen's University Belfast, Belfast, United Kingdom.
Tiny JaarsmaDepartment of Health, Medicine and Caring Science, Linköping University, Linköping, Sweden.
Ewa JankowskaDepartment of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
Emer JoyceDepartment of Cardiology, Mater University Hospital, Dublin, Ireland.
Nicolle KrankelUniversitätsmedizin Berlin Campus Benjamin Franklin Klinik für Kardiologie Charite, Berlin, Germany.
Mitja LainscakGeneral Hospital Murska Sobota, Murska Sobota, Slovenia.
Lars H LundDepartment of Medicine, Karolinska Institutet and Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.
Brenda MouraArmed Forces Hospital, Porto, Portugal.
Kari NytrøenDepartment of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Elena OstoDivision of Physiology and Pathophysiology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria.
Massimo PiepoliDipartimento Scienze Biomediche per la Salute, Universita' Degli Studi di Milan, Milan, Italy.
Luciano PotenaUniversity Hospital of Bologna, Bologna, Italy.
Amina RakishevaDepartment of Cardiology, Scientific Institution of Cardiology and Internal Diseases, Almaty, Kazakhstan.
Giuseppe RosanoSt. George's Hospital NHS Trust University of London, London, United Kingdom.
Gianluigi SavareseDivision of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Petar M SeferovicFaculty of Medicine and Heart Failure Center, University of Belgrade, Belgrade University Medical Center, Belgrade, Serbia.
David R ThompsonSchool of Nursing and Midwifery, Queen's University Belfast, Belfast, United Kingdom.
Thomas ThumInstitute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School and Fraunhofer Institute for Toxicology and Experimental Research, Hannover, Germany.
Emeline M Van CraenenbroeckResearch Group Cardiovascular Diseases, Genetics, Pharmacology and Physiopathology of Heart, Blood Vessels and Skeleton (GENCOR) Department, University of Antwerp, Antwerp, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Little is known either about either physical activity patterns, or other lifestyle-related prevention measures in heart transplantation (HTx) recipients. The history of HTx started more than 50 years ago but there are still no guidelines or position papers highlighting the features of prevention and rehabilitation after HTx. The aims of this scientific statement are (i) to explain the importance of prevention and rehabilitation after HTx, and (ii) to promote the factors (modifiable/non-modifiable) that should be addressed after HTx to improve patients' physical capacity, quality of life and survival. All HTx team members have their role to play in the care of these patients and multidisciplinary prevention and rehabilitation programmes designed for transplant recipients. HTx recipients are clearly not healthy disease-free subjects yet they also significantly differ from heart failure patients or those who are supported with mechanical circulatory support. Therefore, prevention and rehabilitation after HTx both need to be specifically tailored to this patient population and be multidisciplinary in nature. Prevention and rehabilitation programmes should be initiated early after HTx and continued during the entire post-transplant journey. This clinical consensus statement focuses on the importance and the characteristics of prevention and rehabilitation designed for HTx recipients.

Indexed as

Heart FailureHeart TransplantationQuality of LifeConsensusEuropeExerciseHumansSocieties, Medicaldiabetesdyslipidaemiaexercise trainingheart failureheart transplantation

Identifiers

PMID39015154
PMCPMC11250379

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.